Table 3. Medications during hospitalization and after discharge.
| Variable | Pattern of statin therapy use |
P | |||
| Group I | Group II | Group III | Group IV | ||
| (n = 2,653) | (n = 309) | (n = 157) | (n = 465) | ||
| During hospitalization | |||||
| Aspirin | 2,641 (100) | 307 (99) | 143 (99) | 424 (98) | 0.001 |
| Clopidogrel | 2,631 (100) | 306 (99) | 142 (99) | 423 (98) | 0.061 |
| Beta-blocker | 2,183 (82) | 248 (80) | 93 (59) | 313 (67) | < 0.001 |
| ACEI | 1,916 (72) | 196 (63) | 79 (50) | 262 (56) | < 0.001 |
| ARB | 486 (18) | 63 (22) | 31 (20) | 85 (18) | 0.526 |
| After discharge | |||||
| Aspirin | 2,682 (99) | 183 (61) | 156 (99) | 371 (80) | < 0.001 |
| Clopidogrel | 2,362 (89) | 170 (55) | 143 (91) | 330 (71) | < 0.001 |
| Beta-blocker | 2,155 (81) | 145 (47) | 119 (76) | 280 (60) | < 0.001 |
| ACEI | 1,780 (67) | 115 (37) | 86 (55) | 226 (49) | < 0.001 |
Results are presented as n (%). Patterns of statin therapy use: Group I, statin therapy both during hospitalization and after discharge; Group II, only during hospitalization; Group III, only after discharge; and Group IV, no statin therapy. ACEI: angiotensin-converting-enzyme inhibitors; ARB: angiotensin II receptor blockers.